Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
Top 10 High-Yield Dividend Stocks For August 2025
07:15am, Friday, 01'st Aug 2025
My watchlist aims to identify high-quality, high-yield stocks trading at attractive valuations, outperforming benchmarks in yield, and offering strong long-term CAGR. The August 2025 Top 10 list remai
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
Trump pressures 17 pharma CEOs to cut US drug prices
02:28pm, Thursday, 31'st Jul 2025
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
01:48pm, Thursday, 31'st Jul 2025
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
5 Regular Payout High-Yield VIG Dividends to Outpace the Fed
03:11pm, Wednesday, 30'th Jul 2025
These VIG dividend stocks have high yields and regular payouts. Their yields outpace the Federal Reserve's long-term target.
Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?
09:51am, Wednesday, 30'th Jul 2025
MRK targets $3B in annual savings by 2027 as it cuts jobs and refocuses investment ahead of Keytruda's 2028 patent cliff.
Why Merck Stock Slipped Today
04:47pm, Tuesday, 29'th Jul 2025
On Tuesday, Merck (MRK -1.56%) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter resul
Merck Stock Is Almost A Classical Benjamin Graham Investment
03:03pm, Tuesday, 29'th Jul 2025
Merck is good value for money. It is a highly profitable company. It fulfills almost all of Benjamin Graham's stock-picking criteria.
Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript
01:47pm, Tuesday, 29'th Jul 2025
Merck & Co., Inc. (NYSE:MRK ) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET Company Participants Caroline A. Litchfield - Executive VP & CFO Dean Y.
'Halftime' Committee Stocks on the Move: UnitedHealth, Merck, Royal Caribbean and Spotify
01:45pm, Tuesday, 29'th Jul 2025
The Investment Committee debate some of their stocks on the move lower.
Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed
01:11pm, Tuesday, 29'th Jul 2025
MRK beats second-quarter estimates for EPS while matching the same for sales. The company trims its 2025 outlook.
Here's What Key Metrics Tell Us About Merck (MRK) Q2 Earnings
10:35am, Tuesday, 29'th Jul 2025
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street esti
Merck will lay off employees and shed some real estate to cut $3 billion in costs
10:08am, Tuesday, 29'th Jul 2025
Merck's stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include layoffs.
